Skip to main content

MenFive™

Product overview

Vaccine type
Menigococcal ACYWX (Polysaccharide conjugate)
Commercial Name
MenFive™
Manofacturer
Serum Institute of India Pvt. Ltd.
Responsible NRA
Central Drugs Standard Control Organization
Country
India

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Lyophilised active component to be reconstituted with excipient diluent before use
Presentation
Vial + Ampoule
Number of Doses
1
Diluent
0.9% Sodium Chloride
Route of Administration
Intramuscular
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
Vaccine: Carton box of 50 vials (50 doses) [Dimensions:4.5 x 9.5 x 18.5 cm]. Diluent: Carton box of 50 ampoules (50 doses) [Dimensions: 7 x 6 x 14.5 cm]
Tertiary Packaging
Vaccine: Carton box cotaning 6 cartons of 50 vaccine vials (300 vials/300 doses) [Dimensions: 10.3 x 19 x 31 cm]. Diluent: Box containing 24 cartons of 50 ampoules (1200 ampoules/1200 doses) [Dimensions: 24 x 26 x 31 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.
Vaccine Preservative
none
Cold Chain Volume
Vaccine: 15.81 cm3/dose (in secondary packaging)

Attachments

Container Photo
Package Insert UNICEF
Package Insert PAHO